Covered recipient · General Payments record
YUCHEN LIU
Eye and Vision Services Providers Optometrist
General Payments · PY2023–2024
$652.22
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $558.37 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $232.52 | 8 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $121.85 | 1 |
| Oyster Point Pharma, Inc. | $66.59 | 2 |
| Alcon Laboratories Inc | $49.54 | 2 |
| ANI Pharmaceuticals, Inc. | $32.10 | 1 |
| Astellas Pharma US Inc | $28.50 | 1 |
| Tarsus Pharmaceuticals, Inc. | $27.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.69 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892517 | CMS |
| ABBVIE INC. | $27.81 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892519 | CMS |
| ABBVIE INC. | $17.88 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892521 | CMS |
| ABBVIE INC. | $4.31 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892523 | CMS |
| ABBVIE INC. | $4.32 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892525 | CMS |
| ABBVIE INC. | $143.55 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892527 | CMS |
| ABBVIE INC. | $1.02 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892529 | CMS |
| ABBVIE INC. | $15.94 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104892531 | CMS |
| Alcon Vision LLC | $26.30 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110724752 | CMS |
| Alcon Vision LLC | $23.24 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110724750 | CMS |
| ANI Pharmaceuticals, Inc. | $32.10 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091140664 | CMS |
| Astellas Pharma US Inc | $28.50 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139447768 | CMS |
| Oyster Point Pharma, Inc. | $34.13 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147423077 | CMS |
| Oyster Point Pharma, Inc. | $32.46 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147404288 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $121.85 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152212955 | CMS |
| Tarsus Pharmaceuticals, Inc. | $27.27 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139112929 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.